portugues espanhol ingles frances alemao chines(simplificado) russo
Logo Simposio 2024 Logo Malaria 2024

Programação Simpósio

Baixe a Programação atualizada no dia 31/10/2024

2nd Fiocruz-NIAID Symposium:

  • Leonardo Carvalho, Hans Ackerman, Joel Vega-Rodriguez, Giselle Viana (Organizers)
  • Kristin Kelling (Attaché, Department of Health and Human Services, US Embassy, Brasília)
  • Livia Caricio Martins (Director, IEC-SVSA, Belém)
  • Luiz Augusto Galvão (Fiocruz Center for Global Health, Rio de Janeiro)

9:30 am – 9:40 am – Discussion

Moderators: Hans Ackerman (NIAID-NIH) / Beatriz Grinsztejn (INI-Fiocruz)


9:40 am – 11:00 am                    Session 1: Geography, Physical Disruption and Health

  • André M. Siqueira (INI-Fiocruz, Rio de Janeiro) – Infectious diseases in the Yanomami population
  • Maria Elena Crespo Lopez (UFPA, Belem) – Environmental pollution vs public health surveillance in the Global South: the case-study of mercury in Brazil
  • Courtney Murdock (Cornell University, Ithaca) – Landscapes of infection: the role of the environment in shaping host-pathogen interactions, life history, and pathogen transmission
  • Q&A: 20 minutes

Moderators: Gabriel L. Wallau (IAM-Fiocruz) / Helene M. Ueno (USP)



11:20 am – 12:15 am                 Session 2: Sexually Transmitted Infections

  • Beatriz Grinsztejn (INI-Fiocruz, Rio de Janeiro; NIH grantee; President of the International AIDS Society)

– HIV Prevention and STIs in sexual and gender minorities: generating evidence to tackle inequities

  • Antonio Vallinoto (UFPA, Belem) – HTLV-1/2 infection in vulnerable populations of the Brazilian Amazonian State of Pará
  • Q&A: 15 minutes

Moderators: Ricardo Ishak (UFPA) / Vinicius Cotta de Almeida (IOC-Fiocruz)



1:30 pm – 3:10 pm                      Session 3: Vector Borne Diseases and Ecology I

  • Pedro Vasconcelos (IEC-SVSA, Belem) – Factors associated with emergence and reemergence of arboviruses in the Brazilian Amazon
  • Neil Lobo (University of Notre Dame, Indiana) – Utilizing an expanded toolbox of vector control interventions in a changing environment
  • Luiz C. J. Alcantara (IRR-Fiocruz/UFMG, Belo Horizonte; NIH grantee, Arboviral Research Network – UWARN) – Intensive and optimized virus surveillance at the Public Health laboratories and riverside communities: influence of climate change on pathogen emergence and disease intensification
  • André L. Rodrigues Roque (IOC-Fiocruz, Rio de Janeiro) – Ecological scenarios of the orally transmitted Chagas disease outbreaks in Brazil
  • Q&A: 20 minutes

Moderators: Ana Yece N. Pinto (IEC-SVSA) / Elizabeth F. Rangel (IOC-Fiocruz)



3:30 pm – 5:10 pm                      Session 4: Vector Borne Diseases and Ecology II

  • Felipe G. Naveca (ILMD-Fiocruz, Manaus) – Genetic epidemiology of viruses circulating in Amazonia
  • Tovi Lehman (NIAID-NIH, Rockville) – High-altitude windborne mosquitoes and pathogens: opportunities to monitor threats to public health, food security, and ecosystem stability
  • Dhelio B. Pereira (CEPEM-Rondonia, Porto Velho; NIH grantee, Amazonian Center of Excellence in Malaria Research) – An integrated and functional research plan on the Amazonian border: epidemiology, translational medicine and clinical research
  • Marshall E. Bloom (Rocky Mountain Laboratories, NIAID-NIH, Hamilton) – New dimensions in the study of tick-borne viruses
  • Q&A: 20 minutes

Moderators: Rafael Maciel de Freitas (IOC-Fiocruz) / Aline R. Matos (IOC-Fiocruz)


End Program Day 1


8:30 am – 9:00 am                       KEYNOTE ADDRESS: Marco Krieger (Vice-President, Fiocruz, Rio de Janeiro) – How Biomanguinhos take on advanced therapies will impact public health in Brazil

9:00 am – 9:10 am – Discussion

Moderators: Leonardo J. M. Carvalho (IOC-Fiocruz) / Giselle M. R. Viana (IEC-SVSA)


9:10 pm – 10:50 pm                   Session 5: Immunoprevention and Control

  • Robert Seder (NIAID-NIH, Bethesda) – Role of vaccines and monoclonals in response to emerging and re- emerging infectious disease threats
  • Mauricio L. Nogueira (Famerp, São José do Rio Preto; NIH grantee, CREATENEO, Creid) – Vaccines against arboviruses
  • Luis Vicente Rizzo (Albert Einstein Hospital, São Paulo) – The effectiveness of the COVID-19 vaccines in the prevention of post-COVID conditions
  • Gregory Lanzaro (University of California, Davis) – Mendel meets mosquito: the application of gene drive for the elimination of malaria

Q&A: 20 minutes

Moderators: Alexandre Macedo (CDC, Atlanta) / Flavia L. R. Gomes (IOC-Fiocruz)



11:10 am – 12:30 pm               Session 6: Host-parasite interactions and disease transmission

  • Jesus Valenzuela (NIAID-NIH, Rockville) – Impact of vector derived factors on Leishmania establishment and determinants of vector infection and transmission
  • Joel Vega-Rodriguez (NIAID-NIH, Rockville) – How mosquito adaptation to hematophagy shaped the transmission of malaria parasites
  • Luis Fernando Chavez (Indiana University, Bloomington) – Health policy impacts on malaria transmission in Costa Rica
  • Q&A: 20 minutes

1:50 pm – 3:10 pm                     Session 7: Transdisciplinary Engagement and Data Integration

  • Claudia Codeço (PROCC-Fiocruz, Rio de Janeiro) – Trajetorias: a dataset of environmental, epidemiological and economic indicators for the Brazilian Amazon
  • Helder Nakaya (Albert Einstein Hospital, São Paulo; NIH grantee, SARS-CoV-2 mRNA Vaccine-induced Immunity) – From precision medicine to epidemiology: harnessing AI against global health threats
  • Sadie J. Ryan (Florida Climate Institute, University of Florida, Gainesville) – Mapping the future? Where vector borne disease meets climate in a changing World
  • Q&A: 20 minutes

Moderators: Anderson M. Herculano (UFPA) / Francisco Acácio Alves (UFPA)


3:10 pm – 3:30 am                      Closing remarks: Leonardo Carvalho, Hans Ackerman, Joel Vega-Rodriguez, Giselle Viana


3:30 pm – 4:30 pm                     Poster session


3:30 pm – 5:30 pm                      NIH Grant Writing Workshop

  • NIAID research concepts, development of priorities and funding opportunity development
  • Development of a grant application for NIH
  • The grant submission process: foreign eligibility, administrative steps
  • The NIH peer review process, including what reviewers look for and upcoming changes
  • How to interpret summary statements, how to find contacts at NIH
  • Panel Discussion and Q&A, with Panel (5-6 Members) Including: NIAID Program Officers, NIH-funded investigators (including Brazilian investigators with successful NIH grant applications) and investigators who have served as NIH peer reviewers


APOIO E ORGANIZAÇÃO

Quem faz o XVII RNPM

#XVIIRNPMEUVOU!
XVII RNPM © 2024. Todos os direitos reservados.